drugset / Trial / NCT00136383

Comparing Paroxetine and Duloxetine on Cardiovascular Measures

NCT00136383

Phase 2/3 Completed 40 enrolled Duke University GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.

Timeline

Start
2005-03
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule
Subject Paroxetine Small molecule

Indications